Bragar Eagel & Squire is Investigating Certain Officers and Directors of Live Ventures, CorMedix, Emergent BioSolutions, and Generac on Behalf of Long-Term Stockholders and Encourages Investors to Con

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Bragar Eagel & Squire is Investigating Certain Officers and Directors of Live Ventures, CorMedix, Emergent BioSolutions, and Generac on Behalf of Long-Term Stockholders and Encourages Investors to Con

Generac Holdings (GNRC) PT Raised to $575 at Canaccord Genuity

November 3, 2021 8:15 AM EDT

Canaccord Genuity analyst Jed Dorsheimer raised the price target on Generac Holdings (NYSE: GNRC) to $575.00 (from $515.00) while maintaining a Buy rating.

The analyst commented, "We are maintaining our BUY rating and increasing our PT to $575, which is based on applying a multiple... More